Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Non-Current Assets: 2016-2019

Historic Non-Current Assets for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $122,381.

  • Monopar Therapeutics' Non-Current Assets was N/A to $68,858 in Q3 2020 from the same period last year, while for Sep 2020 it was $68,858, marking a year-over-year change of. This contributed to the annual value of $122,381 for FY2019, which is 86.18% up from last year.
  • As of FY2019, Monopar Therapeutics' Non-Current Assets stood at $122,381, which was up 86.18% from $65,731 recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' Non-Current Assets ranged from a high of $800,393 in FY2016 and a low of $65,731 during FY2018.
  • Moreover, its 3-year median value for Non-Current Assets was $122,381 (2019), whereas its average is $329,381.
  • In the last 5 years, Monopar Therapeutics' Non-Current Assets plummeted by 91.78% in 2018 and then surged by 86.18% in 2019.
  • Yearly analysis of 4 years shows Monopar Therapeutics' Non-Current Assets stood at $800,393 in 2016, then declined by 0.05% to $800,031 in 2017, then plummeted by 91.78% to $65,731 in 2018, then soared by 86.18% to $122,381 in 2019.